Brigade Enterprises Limited’s Nomination and Remuneration Committee has approved the allotment of 39,094 equity shares under its ESOP schemes, increasing the paid-up share capital. Additionally, the committee approved the grant of 14,84,344 options under the new ‘Brigade Employee Stock Option Plan 2026’ at an exercise price of ₹525 per option. These decisions were made during a meeting held on October 29, 2026.
ESOP Scheme Allotments Approved
On October 29, 2026, the Nomination and Remuneration Committee of Brigade Enterprises Limited convened and made significant decisions regarding the company’s employee stock option plans. The committee approved the allotment of 8,390 equity shares under the Brigade Employee Stock Option Plan, 2017, and an additional 30,704 equity shares under the Brigade Employee Stock Option Plan rolled out in 2022. These allotments have resulted in an increase of the company’s paid-up share capital from ₹3,26,25,92,830/- to ₹3,26,29,83,770/-.
New Stock Option Grant
Furthermore, the committee approved the grant of 14,84,344 options to eligible employees under a newly established ESOP Plan. This new scheme is named the ‘Brigade Employee Stock Option Plan 2026,’ and the options have been granted with an exercise price of ₹525 per option. This plan is in accordance with the SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021, and the exercise price represents a discount to the closing price of ₹538.35 on October 28, 2026.
Grant Details and Vesting
The total number of shares covered by these granted options is 14,84,344 equity shares, with each option entitling the holder to one equity share of ₹10 each. The options will vest progressively, with 25% vesting annually over a period of four years, contingent upon performance criteria being met. Eligible employees will have a period of five years from the date of vesting to exercise their options. The grant of these options is governed by the ‘Brigade Employee Stock Option Plan 2026’, which received shareholder approval on August 13, 2026, and in-principle approval from NSE and BSE on October 23, 2026.
Source: BSE
